Callahan Advisors’s Core Laboratories CLB Stock Holding History

Callahan Advisors’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,135	Closed	-$247K	–	133
2018 Q3	$247K	Sell	2,135 -50	-2%	-$5.64K	0.05%	128
2018 Q2	$276K	Buy	2,185 +100	+5%	+$12.2K	0.05%	112
2018 Q1	$226K	Buy	2,085 +250	+14%	+$27.7K	0.05%	111
2017 Q4	$201K	Buy	+1,835	New	+$183K	0.04%	118
2017 Q3	–	Sell	-2,075	Closed	-$210K	–	127
2017 Q2	$210K	Buy	2,075 +50	+2%	+$5.39K	0.05%	111
2017 Q1	$234K	Buy	+2,025	New	+$235K	0.05%	110
2015 Q1	–	Sell	-13,325	Closed	-$1.6M	–	115
2014 Q4	$1.6M	Sell	13,325 -2,310	-15%	-$303K	0.47%	64
2014 Q3	$2.29M	Buy	15,635 +735	+5%	+$113K	0.71%	56
2014 Q2	$2.49M	Buy	14,900 +1,075	+8%	+$191K	0.79%	55
2014 Q1	$2.74M	Buy	13,825 +470	+4%	+$88.7K	0.93%	49
2013 Q4	$2.55M	Sell	13,355 -330	-2%	-$61.4K	0.89%	50
2013 Q3	$2.32M	Buy	13,685 +150	+1%	+$23.3K	0.88%	53
2013 Q2	$2.05M	Buy	+13,535	New	+$1.92M	0.84%	53

Other funds holding CLB

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Callahan Advisors's CLB Position: Q4 2018 in Review

Callahan Advisors sold out of Core Laboratories (CLB) in Q4 2018, closing a stake of 2,135 shares — an estimated $247K sold.

Callahan Advisors first reported a position in CLB in Q2 2013 and held it in 13 quarters. The position peaked at $2.74M in Q1 2014. 320 funds tracked by Wall St. Rank hold CLB as of Q4 2018.

Callahan Advisors reported no remaining Core Laboratories position as of Q4 2018 after selling out during the quarter.
Callahan Advisors sold 2,135 Core Laboratories shares in Q4 2018, an estimated $247K.
Callahan Advisors first reported a position in Core Laboratories in Q2 2013 and held it in 13 quarters.
Callahan Advisors's Core Laboratories position peaked at $2.74M in Q1 2014.
320 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2018.

Based on Callahan Advisors's 13F filing for Q4 2018, filed 24 Jan 2019.